Abcam Acquires AxioMx for $45,000,000

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    688 E Main Street Branford, CT 06405 USA
  • Company Description
    AxioMx has developed synthetic recombinant antibody libraries with greater than ten billion unique clones. Diversity in our libraries is restricted to the most variable positions in the complementarity determining regions (CDRs) of natural antibody sequences.
  • Website
  • Transaction Type
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    The life science research tools supplier said Wednesday it has signed an agreement to buy AxioMx on a cash-free/debt-free basis for $20 million upfront with further performance-based payments totaling $25 million.

Trending on Xconomy